Country: United Kingdom
Language: English
Source: MHRA (Medicines & Healthcare Products Regulatory Agency)
Trimethoprim
Crescent Pharma Ltd
J01EA01
Trimethoprim
200mg
Oral tablet
Oral
No Controlled Drug Status
Valid as a prescribable product
BNF: 05010800; GTIN: 5017123322242
Package leaflet: Information for the patient READ ALL OF THIS LEAFLET CAREFULLY BEFORE YOU START TAKING THIS MEDICINE BECAUSE IT CONTAINS IMPORTANT INFORMATION FOR YOU. • Keep this leaflet. You may need to read it again. • If you have any further questions, ask your doctor, pharmacist or nurse. • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours. • If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet. See section 4. P0908T WHAT IS IN THIS LEAFLET 1. What Trimethoprim Tablets are and what they are used for 2. What you need to know before you take Trimethoprim Tablets 3. How to take Trimethoprim Tablets 4. Possible side effects 5. How to store Trimethoprim Tablets 6. Contents of the pack and other information 1. WHAT TRIMETHOPRIM TABLETS ARE AND WHAT THEY ARE USED FOR Trimethoprim belongs to a group of medicines known as anti-bacterials which are effective against a wide range of bacteria. Trimethoprim Tablets may be used: • to treat a wide range of infections including urinary infections and respiratory tract infections. • for long-term prevention of recurrent urinary tract infections. 2. WHAT YOU NEED TO KNOW BEFORE YOU TAKE TRIMETHOPRIM TABLETS DO NOT TAKE TRIMETHOPRIM TABLETS IF: • you are allergic to Trimethoprim or to any of the other ingredients of this medicine (listed in section 6) • you have severe liver problems • you have a blood disorders such as anaemia • you are pregnant or think you may be pregnant. This medicine should not be given to premature babies or babies under 4 months old. The tablet form is NOT recommended for use in children under 6 years - the oral liquid form should be used. WARNINGS AND PRECAUTIONS TALK TO YOUR DOCTOR BEFORE TAKING TRIMETHOPRIM TABLETS IF: • you are pregnant or think you may be pregnant • you have porphyria (a disorder that causes skin sensitivity to light, pain att Read the complete document
SUMMARY OF PRODUCT CHARACTERISTICS 1 NAME OF THE MEDICINAL PRODUCT Trimethoprim Tablets BP 100 mg Trimethoprim Tablets BP 200 mg 2 QUALITATIVE AND QUANTITATIVE COMPOSITION Trimethoprim Tablets BP 100 mg Each tablet contains 100 mg of trimethoprim BP. Excipient with known effect. Trimethoprim Tablets BP 100 mg contains 50mg of lactose. Trimethoprim Tablets BP 200 mg Each tablet contains 200 mg of trimethoprim BP. Excipient with known effect. Trimethoprim Tablets BP 200 mg contains 100mg of lactose. For the full list of excipients, see section 6.1. 3 PHARMACEUTICAL FORM Trimethoprim Tablets BP 100 mg Tablet. White, round, flat bevelled edged tablets, engraved on one side with the company logo and with a breakline and A307 on the other side. The score line is only to facilitate breaking for ease of swallowing and not to divide into equal doses. Trimethoprim Tablets BP 200 mg Tablet. White, round, flat bevelled edged tablets, engraved on one side with the company logo and with a breakline and A322 on the other side. The score line is only to facilitate breaking for ease of swallowing and not to divide into equal doses. 4.1 THERAPEUTIC INDICATIONS Treatment of susceptible infections caused by trimethoprim-sensitive organisms including urinary infections and respiratory tract infections. prophylaxis of recurrent urinary tract infections 4.2 POSOLOGY AND METHOD OF ADMINISTRATION Posology _Acute infections: _ Treatment should continue for a period of between three days (e.g. uncomplicated bacterial cystitis in women) and two weeks according to the nature and severity of infection. The first dose can be doubled. Adults: 200mg twice daily Paediatric population: Children over 12 years: Same as adult dose Children 6 - 12 years: 100 mg twice daily Children under 6 years of age: This dosage form is not suitable for use in children younger than 6 years. Elderly:_ _Dosage is dependent upon kidney function; see special dosage schedule. _Advised dosage Schedule where there is reduced kidney function: _ eGFR (ml/min) Dosage advised Read the complete document